US Stock MarketDetailed Quotes

OTLK Outlook Therapeutics

Watchlist
  • 1.890
  • +0.030+1.61%
Close Dec 31 16:00 ET
  • 1.880
  • -0.010-0.53%
Post 17:46 ET
47.07MMarket Cap-0.47P/E (TTM)

Outlook Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-60.08%-68.79M
-33.28%-16.98M
-47.64%-19.51M
-137.44%-19.27M
-46.41%-13.03M
24.18%-42.97M
-24.30%-12.74M
37.36%-13.22M
43.39%-8.11M
19.01%-8.9M
Net income from continuing operations
-27.78%-75.37M
143.81%5.69M
314.80%44.41M
-1,617.52%-114.29M
40.10%-11.18M
10.70%-58.98M
9.44%-12.99M
-17.87%-20.68M
66.23%-6.65M
-29.04%-18.66M
Operating gains losses
-294.76%-1.05M
-529,695.72%-28.84M
-295,839.99%-56M
5,075,432.12%83.74M
-90.34%50.79K
-11.61%537.74K
-37.62%-5.44K
108.69%18.94K
-105.31%-1.65K
-34.19%525.89K
Depreciation and amortization
157.67%113.86K
156.73%28.8K
156.18%28.67K
156.29%28.2K
161.60%28.2K
-78.41%44.19K
-78.21%11.22K
-78.17%11.19K
-78.47%11K
-78.81%10.78K
Other non cash items
95.58%2.68M
--0
--0
--1.69M
-27.58%993K
-45.98%1.37M
--0
--0
--0
170.42%1.37M
Change In working capital
-163.49%-3.02M
312.25%4.22M
-156.72%-1.78M
55.84%-1.26M
-164.98%-4.2M
382.19%4.75M
-189.78%-1.99M
156.28%3.14M
-474.19%-2.86M
608.97%6.46M
-Change in prepaid assets
-287.29%-4.9M
-38.27%1.1M
-2,764.49%-3.04M
-595.95%-524.12K
-410.12%-2.45M
184.61%2.62M
30.80%1.79M
103.38%113.96K
90.67%-75.31K
376.18%788.51K
-Change in payables and accrued expense
-20.47%1.89M
181.20%3.09M
-60.65%1.28M
73.60%-731.16K
-130.84%-1.75M
63.40%2.37M
-543.20%-3.8M
248.51%3.26M
-275.18%-2.77M
370.87%5.68M
-Change in other current assets
97.17%-5.9K
-4.38%22.97K
90.11%-22.97K
----
----
---208.2K
--24.02K
---232.22K
----
----
-Change in other current liabilities
112.64%3.41K
--5.63K
43.50%-2.22K
--0
--0
37.01%-27K
--0
63.94%-3.93K
-11.06%-11.64K
-11.27%-11.42K
Cash from discontinued investing activities
Operating cash flow
-60.08%-68.79M
-33.28%-16.98M
-47.64%-19.51M
-137.44%-19.27M
-46.41%-13.03M
24.18%-42.97M
-24.30%-12.74M
37.36%-13.22M
43.39%-8.11M
19.01%-8.9M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
23.20%60.33M
-104.74%-114.95K
30.69%4.31M
9,501.66%56.14M
-100.01%-3.18K
-17.83%48.97M
49.08%2.42M
129.16%3.3M
-122.90%-597.13K
-34.23%43.85M
Net issuance payments of debt
-100.02%-4.27K
--0
--0
62.48%-1.08K
-100.02%-3.18K
952.41%19.77M
45.79%-3.08K
99.97%-2.98K
99.06%-2.89K
106.20%19.78M
Net common stock issuance
100.95%60.33M
-104.74%-114.95K
30.57%4.31M
16,647.34%56.14M
--0
-51.81%30.02M
48.75%2.43M
1,025.98%3.3M
-112.44%-339.28K
-57.27%24.64M
Net other financing activities
----
----
----
----
----
-37.32%-823.89K
--0
--0
---254.96K
5.18%-568.93K
Cash from discontinued financing activities
Financing cash flow
23.20%60.33M
-104.74%-114.95K
30.69%4.31M
9,501.66%56.14M
-100.01%-3.18K
-17.83%48.97M
49.08%2.42M
129.16%3.3M
-122.90%-597.13K
-34.23%43.85M
Net cash flow
Beginning cash position
34.46%23.39M
-5.00%32.02M
8.25%47.23M
-80.21%10.36M
34.46%23.39M
20.17%17.4M
29.54%33.71M
-25.32%43.63M
-25.39%52.34M
20.17%17.4M
Current changes in cash
-241.19%-8.46M
-65.71%-17.1M
-53.27%-15.2M
523.25%36.87M
-137.30%-13.04M
105.35%6M
-19.62%-10.32M
69.39%-9.92M
25.71%-8.71M
-37.23%34.94M
End cash Position
-36.19%14.93M
-36.19%14.93M
-5.00%32.02M
8.25%47.23M
-80.21%10.36M
34.46%23.39M
34.46%23.39M
29.54%33.71M
-25.32%43.63M
-25.39%52.34M
Free cash flow
-60.08%-68.79M
-33.28%-16.98M
-47.64%-19.51M
-137.44%-19.27M
-46.41%-13.03M
24.18%-42.97M
-24.30%-12.74M
37.36%-13.22M
43.39%-8.11M
19.01%-8.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -60.08%-68.79M-33.28%-16.98M-47.64%-19.51M-137.44%-19.27M-46.41%-13.03M24.18%-42.97M-24.30%-12.74M37.36%-13.22M43.39%-8.11M19.01%-8.9M
Net income from continuing operations -27.78%-75.37M143.81%5.69M314.80%44.41M-1,617.52%-114.29M40.10%-11.18M10.70%-58.98M9.44%-12.99M-17.87%-20.68M66.23%-6.65M-29.04%-18.66M
Operating gains losses -294.76%-1.05M-529,695.72%-28.84M-295,839.99%-56M5,075,432.12%83.74M-90.34%50.79K-11.61%537.74K-37.62%-5.44K108.69%18.94K-105.31%-1.65K-34.19%525.89K
Depreciation and amortization 157.67%113.86K156.73%28.8K156.18%28.67K156.29%28.2K161.60%28.2K-78.41%44.19K-78.21%11.22K-78.17%11.19K-78.47%11K-78.81%10.78K
Other non cash items 95.58%2.68M--0--0--1.69M-27.58%993K-45.98%1.37M--0--0--0170.42%1.37M
Change In working capital -163.49%-3.02M312.25%4.22M-156.72%-1.78M55.84%-1.26M-164.98%-4.2M382.19%4.75M-189.78%-1.99M156.28%3.14M-474.19%-2.86M608.97%6.46M
-Change in prepaid assets -287.29%-4.9M-38.27%1.1M-2,764.49%-3.04M-595.95%-524.12K-410.12%-2.45M184.61%2.62M30.80%1.79M103.38%113.96K90.67%-75.31K376.18%788.51K
-Change in payables and accrued expense -20.47%1.89M181.20%3.09M-60.65%1.28M73.60%-731.16K-130.84%-1.75M63.40%2.37M-543.20%-3.8M248.51%3.26M-275.18%-2.77M370.87%5.68M
-Change in other current assets 97.17%-5.9K-4.38%22.97K90.11%-22.97K-----------208.2K--24.02K---232.22K--------
-Change in other current liabilities 112.64%3.41K--5.63K43.50%-2.22K--0--037.01%-27K--063.94%-3.93K-11.06%-11.64K-11.27%-11.42K
Cash from discontinued investing activities
Operating cash flow -60.08%-68.79M-33.28%-16.98M-47.64%-19.51M-137.44%-19.27M-46.41%-13.03M24.18%-42.97M-24.30%-12.74M37.36%-13.22M43.39%-8.11M19.01%-8.9M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 23.20%60.33M-104.74%-114.95K30.69%4.31M9,501.66%56.14M-100.01%-3.18K-17.83%48.97M49.08%2.42M129.16%3.3M-122.90%-597.13K-34.23%43.85M
Net issuance payments of debt -100.02%-4.27K--0--062.48%-1.08K-100.02%-3.18K952.41%19.77M45.79%-3.08K99.97%-2.98K99.06%-2.89K106.20%19.78M
Net common stock issuance 100.95%60.33M-104.74%-114.95K30.57%4.31M16,647.34%56.14M--0-51.81%30.02M48.75%2.43M1,025.98%3.3M-112.44%-339.28K-57.27%24.64M
Net other financing activities ---------------------37.32%-823.89K--0--0---254.96K5.18%-568.93K
Cash from discontinued financing activities
Financing cash flow 23.20%60.33M-104.74%-114.95K30.69%4.31M9,501.66%56.14M-100.01%-3.18K-17.83%48.97M49.08%2.42M129.16%3.3M-122.90%-597.13K-34.23%43.85M
Net cash flow
Beginning cash position 34.46%23.39M-5.00%32.02M8.25%47.23M-80.21%10.36M34.46%23.39M20.17%17.4M29.54%33.71M-25.32%43.63M-25.39%52.34M20.17%17.4M
Current changes in cash -241.19%-8.46M-65.71%-17.1M-53.27%-15.2M523.25%36.87M-137.30%-13.04M105.35%6M-19.62%-10.32M69.39%-9.92M25.71%-8.71M-37.23%34.94M
End cash Position -36.19%14.93M-36.19%14.93M-5.00%32.02M8.25%47.23M-80.21%10.36M34.46%23.39M34.46%23.39M29.54%33.71M-25.32%43.63M-25.39%52.34M
Free cash flow -60.08%-68.79M-33.28%-16.98M-47.64%-19.51M-137.44%-19.27M-46.41%-13.03M24.18%-42.97M-24.30%-12.74M37.36%-13.22M43.39%-8.11M19.01%-8.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Heat List
US
Overall
Symbol
Price
% Chg

No Data